semaglutide medicaid Biden Proposes Coverage of Obesity Drugs in Medicare, CT's new Medicaid prior authorization

Semaglutide is a single (GLP-1) agonist and tirzepatide is a dual (GIP + GLP-1) agonist, while Retatrutide is a triple agonist adding the glucagon receptor

These are oral medications with long safety track records and relatively straightforward production requirements

Is it Safe

For a 2 mg target dose: Volume to Draw = Desired DoseConcentration = 2 mg5 mg/mL = 0.4 mL Convert to syringe units

Cautious use of parenteral cyanocobalamin is also recommended in patients with renal impairment, including premature neonates, because of the possibility of greater aluminum accumulation, which may cause central nervous system and bone toxicity